Trial Profile
A trial of human antithrombin III
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs Antithrombin III (Primary)
- Indications Antithrombin III deficiency
- Focus Adverse reactions; First in man
- 25 Oct 2016 New trial record
- 11 Oct 2016 According to a China Biologic Products, Inc. media release, the China Food and Drug Administration (CFDA) has granted approval to begin human clinical trials with Human Antithrombin III product.